Skip to content

Inspire Medical Systems INSP Market capitalization

Market capitalization at other companies

ResMed logo
ResMedRMD
$32.7B-0.5%
LivaNova logo
LivaNovaLIVN
$3.48B+62.8%
Globus Medical logo
Globus MedicalGMED
$11.65B+15.7%
Stryker logo
StrykerSYK
$125.84B-11.4%
ITG
Integer HoldingsITGR
$3.03B-27.0%
Medtronic logo
MedtronicMDT
$103.96B-3.8%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Computed from the period-end share price: $1.49B.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's market capitalization?
Inspire Medical Systems (INSP) reported market capitalization of $1.49B in Q1 2026.
How has Inspire Medical Systems's market capitalization changed year-over-year?
Inspire Medical Systems's market capitalization decreased by 68.7% year-over-year, from $4.74B to $1.49B.
What is the long-term trend for Inspire Medical Systems's market capitalization?
Over 5 years (2020 to 2025), Inspire Medical Systems's market capitalization has grown at a -12.2% compound annual growth rate (CAGR), from $5.15B to $2.68B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.